Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Diffuse optical imaging of the healthy and diseased breast: a systematic review.

Leff DR, Warren OJ, Enfield LC, Gibson A, Athanasiou T, Patten DK, Hebden J, Yang GZ, Darzi A.

Breast Cancer Res Treat. 2008 Mar;108(1):9-22. Epub 2007 Apr 28. Review.

PMID:
17468951
2.

Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial.

Poellinger A, Persigehl T, Mahler M, Bahner M, Ponder SL, Diekmann F, Bremer C, Moesta T.

Invest Radiol. 2011 Nov;46(11):697-704. doi: 10.1097/RLI.0b013e318229ff25.

PMID:
21788905
3.

Review of optical breast imaging and spectroscopy.

Grosenick D, Rinneberg H, Cubeddu R, Taroni P.

J Biomed Opt. 2016 Sep;21(9):091311. doi: 10.1117/1.JBO.21.9.091311. Review.

PMID:
27403837
4.

Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo.

Rinneberg H, Grosenick D, Moesta KT, Mucke J, Gebauer B, Stroszczynski C, Wabnitz H, Moeller M, Wassermann B, Schlag PM.

Technol Cancer Res Treat. 2005 Oct;4(5):483-96.

PMID:
16173820
5.

A systematic review of the effects of diffuse optical imaging in breast diseases.

Akbari Sari A, Mobinizadeh M, Azadbakht M.

Iran J Cancer Prev. 2013 Winter;6(1):44-51. Review.

6.

Assessing the future of diffuse optical imaging technologies for breast cancer management.

Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE.

Med Phys. 2008 Jun;35(6):2443-51.

7.

Time-domain optical mammography SoftScan: initial results.

Intes X.

Acad Radiol. 2005 Aug;12(8):934-47. Erratum in: Acad Radiol. 2005 Oct;12(10):1355.

PMID:
16023382
8.

Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.

Schneider P, Piper S, Schmitz CH, Schreiter NF, Volkwein N, Lüdemann L, Malzahn U, Poellinger A.

Rofo. 2011 Oct;183(10):956-63. doi: 10.1055/s-0031-1281726. Epub 2011 Oct 4.

PMID:
21972043
9.

Spatial and spectral information in optical mammography.

Fantini S, Heffer EL, Pera VE, Sassaroli A, Liu N.

Technol Cancer Res Treat. 2005 Oct;4(5):471-82.

PMID:
16173819
10.

Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force.

Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009. Review.

11.

Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Ringash J; Canadian Task Force on Preventive Health Care.

CMAJ. 2001 Feb 20;164(4):469-76. Review. Erratum in: CMAJ 2001 Mar 20;164(6):753.

12.

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone.

Gilbert FJ, Tucker L, Gillan MG, Willsher P, Cooke J, Duncan KA, Michell MJ, Dobson HM, Lim YY, Purushothaman H, Strudley C, Astley SM, Morrish O, Young KC, Duffy SW.

Health Technol Assess. 2015 Jan;19(4):i-xxv, 1-136. doi: 10.3310/hta19040.

13.

Digital mammography for screening and diagnosis of breast cancer: an overview.

Van Ongeval Ch.

JBR-BTR. 2007 May-Jun;90(3):163-6. Review.

PMID:
17696081
14.

Dynamic imaging: scintimammography.

Salvatore M, Del Vecchio S.

Eur J Radiol. 1998 May;27 Suppl 2:S259-64. Review.

PMID:
9652532
15.

Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions.

Parisky YR, Sardi A, Hamm R, Hughes K, Esserman L, Rust S, Callahan K.

AJR Am J Roentgenol. 2003 Jan;180(1):263-9.

PMID:
12490517
16.

[Mammography].

Grégoire A, Bernard C, Lavallée G, Morin C, Philie M.

Union Med Can. 1992 Jul-Aug;121(4):239-42. French.

PMID:
1413293
17.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

18.

Current status of digital mammography for screening and diagnosis of breast cancer.

Van Ongeval C, Bosmans H, Van Steen A.

Curr Opin Oncol. 2006 Nov;18(6):547-54. Review.

PMID:
16988574
19.

Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments.

Ebert B, Sukowski U, Grosenick D, Wabnitz H, Moesta KT, Licha K, Becker A, Semmler W, Schlag PM, Rinneberg H.

J Biomed Opt. 2001 Apr;6(2):134-40.

PMID:
11375722
20.

Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.

Tolmos J, Cutrone JA, Wang B, Vargas HI, Stuntz M, Mishkin FS, Diggles LE, Venegas RJ, Klein SR, Khalkhali I.

J Natl Cancer Inst. 1998 Jun 3;90(11):846-9.

PMID:
9625173

Supplemental Content

Support Center